Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

Rhea-AI Summary

Xtant Medical Holdings, Inc. (NYSE American: XTNT) is set to release its financial results for the fourth quarter and full year ended December 31, 2022, before the market opens on March 7, 2023. The results will be discussed in a conference call hosted by CEO Sean Browne and CFO Scott Neils at 9:00 AM ET on the same day. Investors can participate by calling 877-407-6184 or registering for the webcast on the company’s website. Xtant specializes in surgical solutions for spinal disorders, focusing on orthobiologics and spinal implant systems designed to facilitate spinal fusion.

Positive

• Scheduled release of financial results for Q4 and FY 2022, indicating transparency to investors.

Negative

• None.

BELGRADE, Mont., March 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, before the open of the financial markets on Tuesday, March 7, 2023.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Tuesday, March 7 at 9:00 AM ET to review results.

Conference Details:
Conference Date: Tuesday, March 7, 2023 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q4 2022 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ^® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com

FAQ

When will Xtant Medical release its Q4 2022 financial results?

Xtant Medical will release its Q4 2022 financial results on March 7, 2023, before market open.

What time is the conference call for Xtant Medical's financial results?

The conference call for Xtant Medical's financial results is scheduled for 9:00 AM ET on March 7, 2023.

How can I access the Xtant Medical Q4 2022 earnings call?

You can access the Xtant Medical Q4 2022 earnings call by dialing 877-407-6184 or registering for the webcast on their website.

What does Xtant Medical focus on in its business?

Xtant Medical focuses on designing and commercializing surgical solutions for spinal disorders, including orthobiologics and spinal implant systems.